Clinical Trial Update: "Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study" [Phase 4]

View source ↗

Summary

A Phase 4 pilot study completed that evaluated the pharmacoeconomic aspects of autophagy inhibition in hepatitis C patients resistant to standard therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Hepatitis C Virus | Phase 4 | Status: COMPLETED